Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene

Autor: Milène Vandal, A. David Bennett, Ariane Giguère-Rancourt, Frédéric Calon, Cyntia Tremblay, Marine Tournissac, Marie-Thérèse Traversy
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Apolipoprotein E
Genetically modified mouse
medicine.medical_specialty
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Apolipoprotein E4
Receptor for Advanced Glycation End Products
Apolipoprotein E3
Mice
Transgenic

tau Proteins
Article
03 medical and health sciences
Mice
0302 clinical medicine
Endocrinology
Internal medicine
mental disorders
medicine
Animals
Humans
Hypoglycemic Agents
Insulin
Phosphorylation
Receptor
Protein kinase B
Biological Psychiatry
PI3K/AKT/mTOR pathway
Cerebral Cortex
biology
Endocrine and Autonomic Systems
Receptor
Insulin

Psychiatry and Mental health
Insulin receptor
030104 developmental biology
biology.protein
lipids (amino acids
peptides
and proteins)

Signal transduction
human activities
Proto-Oncogene Proteins c-akt
030217 neurology & neurosurgery
Zdroj: Psychoneuroendocrinology
Popis: Apolipoprotein E epsilon-4 ( APOEe4 or APOE4 ), an allelic variation of the APOE gene, not only increases the risk of developing the late-onset form of Alzheimer’s disease (AD), but also influences the outcome of treatment. Indeed, data from clinical studies show that the beneficial effect of insulin on cognition is blunted in APOE4 carriers. To investigate how APOE impacts insulin response, we assessed the effects of an acute insulin injection in APOE3 - and APOE4 -targeted replacement mice that respectively express the human APOE3 or APOE4 isoform instead of the endogenous murine ApoE protein. We evaluated cognition, insulin signaling and proteins implicated in Aβ transport and tau phosphorylation in the cortex and brain capillaries. We found that a single acute insulin injection increased Akt pSer473 in APOE4 compared to APOE3 mice (+113% versus +78.5%), indicating that APOE4 carriage potentiates activation of insulin upstream signaling pathway in the brain. Insulin also led to decreased concentrations of the receptor for advanced glycation endproducts (RAGE) in brain capillaries in both groups of mice. Moreover, higher phosphorylation of tau at Ser202, one of the key markers of AD neuropathology, was observed in insulin-injected APOE4 mice (+44%), consistent with findings in human APOE4 carriers (+400% compared to non-carriers). Therefore, our data suggest that APOE4 carriage leads to an increased insulin-induced activation of cerebral Akt pathway, associated with higher AD-like tau neuropathology. Our results provide evidence of altered insulin signaling in APOE4 carriers as well as a possible mechanism to explain the absence of cognitive benefit from insulin therapy in these individuals.
Databáze: OpenAIRE